Exela PharmSci Inc

Allergan Inc.’s patent infringement suit against Exela PharmSci, Inc. and Apotex, Inc. remains pending.

In February 2007, the Company received a paragraph 4 invalidity and noninfringement Hatch-Waxman Act certification from Exela…

Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and Apotex Inc. is ongoing in the U.S. District Court for the District of Delaware.

In February 2007, the Company and…

The U.S. District Court for the District of Delaware has scheduled a trial date for March 9, 2009, in Allergan Inc.’s consolidated patent infringement suit against Exela PharmSci Inc. and…